Investors in Celldex Therapeutics, Inc. (CLDX - Get Report) saw new options become available this week, for the October 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CLDX options chain for the new October 20th contracts and identified the following call contract of particular interest.The call contract at the $3.00 strike price has a current bid of 10 cents. If an investor was to purchase shares of CLDX stock at the current price level of $2.31/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $3.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 34.20% if the stock gets called away at the October 20th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if CLDX shares really soar, which is why looking at the trailing twelve month trading history for Celldex Therapeutics, Inc., as well as studying the business fundamentals becomes important. Below is a chart showing CLDX's trailing twelve month trading history, with the $3.00 strike highlighted in red: Considering the fact that the $3.00 strike represents an approximate 30% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 64%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 4.33% boost of extra return to the investor, or 26.78% annualized, which we refer to as the YieldBoost. The implied volatility in the call contract example above is 109%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $2.31) to be 57%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
More from Stocks
Park-Ohio Holdings: An Under-the-Radar Opportunity
The diversified manufacturing and supply chain management company holds big upside potential based on expectations of earnings ahead.
Forget Official Data, What Is Chinese Data Really Saying?
Capital outflows are twice as large today as they were the last time China devalued.
Netflix, Bank of America, Opioid Settlement, Brexit, MGM- 5 Things You Must Know
U.S. stock futures decline as Wall Street awaits another round of third-quarter earnings reports and global stocks trade mixed as investors monitored Brexit developments; Netflix, IBM and Bank of America report earnings Wednesday; McKesson, AmerisourceBergen and Cardinal Health reportedly are in talks to pay $18 billion to settle thousands of opioid-related lawsuits.
Johnson & Johnson Gains On Opioid Settlement Reports; Distribution Firms Surge
Johnson & Johnson extended gains in pre-market trading Wednesday amid reports it could be close to agreeing a multi-billion dollar settlement with state attorneys general over its role in the nation's opioid crisis.